How to balance safety, compliance and speed when qualifying raw materials for very different stem cell therapy purposes like cell banking or drug product manufacture for Clinical Phase I/II, Phase III or the Market?
Check out the incredible speaker line-up to see who will be joining Pernille Linnert.
The browser you are using is not supported that will prevent you from accessing certain features of the website. We want you to have the best possible experience. For this you'll need to use a supported browser and upgrade to the latest version.